CA1162479A - Pharmaceutical formulations containing cisplatin - Google Patents

Pharmaceutical formulations containing cisplatin

Info

Publication number
CA1162479A
CA1162479A CA000372499A CA372499A CA1162479A CA 1162479 A CA1162479 A CA 1162479A CA 000372499 A CA000372499 A CA 000372499A CA 372499 A CA372499 A CA 372499A CA 1162479 A CA1162479 A CA 1162479A
Authority
CA
Canada
Prior art keywords
cisplatin
solution
polyethylene glycol
sterile
per
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000372499A
Other languages
English (en)
French (fr)
Inventor
Murray A. Kaplan
Alphonse P. Granatek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of CA1162479A publication Critical patent/CA1162479A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA000372499A 1980-03-31 1981-03-06 Pharmaceutical formulations containing cisplatin Expired CA1162479A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31
US135,373 1980-03-31

Publications (1)

Publication Number Publication Date
CA1162479A true CA1162479A (en) 1984-02-21

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000372499A Expired CA1162479A (en) 1980-03-31 1981-03-06 Pharmaceutical formulations containing cisplatin

Country Status (30)

Country Link
JP (1) JPS56152415A (sv)
KR (1) KR860000841B1 (sv)
AR (1) AR225500A1 (sv)
AT (1) AT370996B (sv)
AU (1) AU541056B2 (sv)
BE (1) BE888209A (sv)
CA (1) CA1162479A (sv)
CH (1) CH647481A5 (sv)
CS (1) CS246051B2 (sv)
DD (1) DD157762A5 (sv)
DE (1) DE3112272A1 (sv)
DK (1) DK158564C (sv)
ES (1) ES500869A0 (sv)
FI (1) FI70670C (sv)
FR (1) FR2480605A1 (sv)
GB (1) GB2074028B (sv)
GR (1) GR72769B (sv)
HU (1) HU183379B (sv)
IE (1) IE51070B1 (sv)
IL (1) IL62517A (sv)
IT (1) IT1170838B (sv)
LU (1) LU83270A1 (sv)
NL (1) NL8101531A (sv)
NO (1) NO156675C (sv)
NZ (1) NZ196519A (sv)
PH (1) PH17152A (sv)
PT (1) PT72774B (sv)
SE (1) SE455045B (sv)
SU (1) SU1056893A3 (sv)
ZA (1) ZA812084B (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3773498B1 (en) 2018-03-29 2022-06-22 Project Pharmaceutics GmbH Liquid pharmaceutical formulation

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
DE69725747T2 (de) * 1996-08-23 2004-07-29 Sequus Pharmaceuticals, Inc., Menlo Park Liposome enthaltend cisplatin
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3773498B1 (en) 2018-03-29 2022-06-22 Project Pharmaceutics GmbH Liquid pharmaceutical formulation
US11752135B2 (en) 2018-03-29 2023-09-12 Project Pharmaceutics Gmbh Liquid pharmaceutical formulation

Also Published As

Publication number Publication date
GB2074028A (en) 1981-10-28
BE888209A (fr) 1981-09-30
FR2480605B1 (sv) 1984-05-11
DE3112272C2 (sv) 1990-09-27
AR225500A1 (es) 1982-03-31
DK144281A (da) 1981-10-01
DD157762A5 (de) 1982-12-08
JPS6360008B2 (sv) 1988-11-22
DK158564C (da) 1990-11-05
IE51070B1 (en) 1986-09-17
NZ196519A (en) 1983-06-17
IE810715L (en) 1981-09-30
IL62517A (en) 1984-01-31
SU1056893A3 (ru) 1983-11-23
DK158564B (da) 1990-06-11
ES8206545A1 (es) 1982-08-16
IL62517A0 (en) 1981-05-20
AU6816681A (en) 1981-10-08
AT370996B (de) 1983-05-25
CH647481A5 (fr) 1985-01-31
HU183379B (en) 1984-04-28
PT72774B (en) 1982-11-16
DE3112272A1 (de) 1982-04-29
PT72774A (en) 1981-04-01
GB2074028B (en) 1983-09-21
SE455045B (sv) 1988-06-20
ZA812084B (en) 1982-04-28
NO156675C (no) 1987-11-04
JPS56152415A (en) 1981-11-26
FI810934L (fi) 1981-10-01
KR830004849A (ko) 1983-07-20
FR2480605A1 (fr) 1981-10-23
PH17152A (en) 1984-06-13
ATA150481A (de) 1982-10-15
IT8148090A0 (it) 1981-03-24
FI70670C (fi) 1986-10-06
CS246051B2 (en) 1986-10-16
FI70670B (fi) 1986-06-26
IT1170838B (it) 1987-06-03
NL8101531A (nl) 1981-10-16
AU541056B2 (en) 1984-12-13
LU83270A1 (fr) 1981-10-29
KR860000841B1 (ko) 1986-07-09
NO156675B (no) 1987-07-27
GR72769B (sv) 1983-12-02
SE8101990L (sv) 1981-11-13
ES500869A0 (es) 1982-08-16
NO811081L (no) 1981-10-01

Similar Documents

Publication Publication Date Title
US4451447A (en) Pharmaceutical formulations
US4322391A (en) Process for the preparation of microcrystalline cisplatin
FI78236B (fi) Foerfarande foer framstaellning av en frystorkad doseringsenhet av cis-platina (ii) diamindiklorid.
Cisar et al. Polybismuth anions. Synthesis and crystal structure of a salt of the tetrabismuthide (2-) ion, Bi42-. A basis for the interpretation of the structure of some complex intermetallic phases
US4310515A (en) Pharmaceutical compositions of cisplatin
CA1162479A (en) Pharmaceutical formulations containing cisplatin
KR100351713B1 (ko) 백금(ii) 항종양제의 안정용액
Corbridge et al. Structure of white phosphorus: single crystal X-ray examination
CA1119954A (en) Aqueous solution of cisplatin
CN104800828A (zh) 用于治疗癌症的有机砷化合物和方法
Boucher Stereochemistry of. beta.-diketone complexes of cobalt (III). IV. Optical activity of cis-diamminebis (acetylacetonato) cobalt (III) cations
FI88165C (sv) Förfarande för framställning av cis-diammin-1,1-cyklobutandikarboxylat -platina(II)komplex
US4946689A (en) Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin
Dougherty et al. The interaction between prothidium dibromide and DNA at the molecular level
AU623632B2 (en) A solution of carboplatin
FI72302B (fi) Foerfarande foer framstaellning av stabilt mikrokristallint ciplatin
Fa et al. SYNTHESIS AND CHARACTERIZATION IN VITRO ANTIMICROBIAL AND CYTOTOXICITY TESTING OF OXALIC ACID-DERIVED CADMIUM CHELATING AGENTS
Bisi Complexes of lanthanide (III) chlorides with 1, 6-dimethyl-4-pyrone
Fulton et al. Changes in cis-and trans-stilbamidine solutions on exposure to light
Haghighi Preparation and Reactivity of Platinum Coordination Complexes
IE51468B1 (en) Microcrystalline cisplatin and formulations containing it

Legal Events

Date Code Title Description
MKEX Expiry